National Medical Insurance Drug Catalogue Adjustment: Priority of Drugs for Cancer and Other Drugs

category:Global click:7
 National Medical Insurance Drug Catalogue Adjustment: Priority of Drugs for Cancer and Other Drugs


The adjustment of drug catalogue involves three aspects: western medicine, Chinese patent medicine and Chinese herbal pieces, including drug import and drug export. Priority should be given to medication for major diseases such as national essential drugs, cancer and rare diseases, medication for chronic diseases, medication for children, first aid and rescue, etc.

Transfer can be divided into two ways: routine access and negotiation access. On the premise of meeting the validity and safety, the price (fee) is comparable to or lower than the existing varieties in the drug catalogue, which can be included in the catalogue by routine means. Patented exclusive drugs with higher prices or greater impact on the health insurance fund should be admitted through negotiation. The adjustment of drug catalogue can be divided into five stages: preparation, evaluation, publication of routine access catalogue, negotiation and publication of negotiation access catalogue. In June, a new version of the drug catalogue was issued and the list of drugs to be negotiated was published. Negotiated drugs should be included in the drug catalogue, and a unified national medical insurance payment standard and management policy should be established. In August, the State Medical Insurance Bureau issued a document to include the successfully negotiated drugs in the drug catalogue, and to clarify the management and implementation requirements simultaneously. The public can submit their opinions by e-mail or other means before March 26. Source: Liu Yuxin_NBJS7825, Responsible Editor of Peoples Network-Peoples Daily

Transfer can be divided into two ways: routine access and negotiation access. On the premise of meeting the validity and safety, the price (fee) is comparable to or lower than the existing varieties in the drug catalogue, which can be included in the catalogue by routine means. Patented exclusive drugs with higher prices or greater impact on the health insurance fund should be admitted through negotiation.

The adjustment of drug catalogue can be divided into five stages: preparation, evaluation, publication of routine access catalogue, negotiation and publication of negotiation access catalogue. In June, a new version of the drug catalogue was issued and the list of drugs to be negotiated was published. Negotiated drugs should be included in the drug catalogue, and a unified national medical insurance payment standard and management policy should be established. In August, the State Medical Insurance Bureau issued a document to include the successfully negotiated drugs in the drug catalogue, and to clarify the management and implementation requirements simultaneously.

The public can submit their opinions by e-mail or other means before March 26.